← Back to Search

Lay Health Worker Intervention for Cancer (LEAPS Trial)

N/A
Waitlist Available
Led By Manali I Patel, MD MPH MS
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up last 30 days of life up to 12 months from patient enrollment
Awards & highlights

LEAPS Trial Summary

This trial aims to see if having a lay health worker helps patients with cancer feel more satisfied with their care, and if it improves quality of life and health resource utilization.

Eligible Conditions
  • End of Life
  • Cancer

LEAPS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~last 30 days of life
This trial's timeline: 3 weeks for screening, Varies for treatment, and last 30 days of life for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Advance Directive Documentation (Chart Review)
Emergency Department Visit (Chart Review)
Goals of Care Documentation (Chart Review)
+12 more

LEAPS Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention Group ArmExperimental Treatment2 Interventions
Patients randomized into the intervention will be assigned a lay health worker who will contact the patient to begin the intervention. The intervention includes: education on early advance care planning, documenting goals of care, assessing symptoms, and coordinating community services (such as home health, home visits, and home hospice). The intervention arm will also receive usual care as provided by Unite Here Health and their local oncologists.
Group II: Control Group ArmActive Control1 Intervention
The control group arm will receive usual care as provided by Unite Here Health and their local oncologists.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Lay Health Worker Intervention
2013
N/A
~400

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,386 Previous Clinical Trials
17,333,848 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,696 Previous Clinical Trials
6,952,428 Total Patients Enrolled
National Institute on Minority Health and Health Disparities (NIMHD)NIH
380 Previous Clinical Trials
1,215,494 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it currently possible to sign up for this research trial?

"Data from clinicaltrials.gov suggests that this trial has finished recruiting participants, as the last edit to its information was made on October 31st 2022. Nevertheless, there are 570 other ongoing studies currently looking for patients."

Answered by AI

What is the ultimate objective of this research endeavor?

"The primary outcome of this clinical trial, to be assessed within four months from patient enrollment, is the alteration in their Quality of Life as measured by the Functional Assessment of Cancer Therapy - General Survey. Secondary objectives include Hospice Use (abstracted via chart review for patients who have deceased within 12 months), Hospitalization Visits (also abstracted through chart review) and Patient Activation using a validated survey at 12 month intervals after study enrollment."

Answered by AI
~25 spots leftby Apr 2025